Protara Therapeutics, Inc. Other Nonoperating Income (Expense)
Protara Therapeutics, Inc. (TARA) reported Other Nonoperating Income (Expense) of $2.00 thousand for the 3-month period ending 2019-09-30, per its 10-Q filed 2019-10-31.
Discontinued › Income Statement › Other Income
us-gaap:OtherNonoperatingIncomeExpense · last filed 2020-03-20
- Protara Therapeutics, Inc. other nonoperating income (expense) for the quarter ending 2019-09-30 was $2.00K.
- Protara Therapeutics, Inc. other nonoperating income (expense) for the quarter ending 2019-06-30 was -$2.00K, a 113.33% decline year-over-year.
- Protara Therapeutics, Inc. other nonoperating income (expense) for the quarter ending 2019-03-31 was $1.00K, a 99.48% decline year-over-year.
- Protara Therapeutics, Inc. other nonoperating income (expense) for the quarter ending 2018-12-31 was $1.00K.
- Protara Therapeutics, Inc. other nonoperating income (expense) for fiscal 2018 was $207.00K, a 48.92% increase from fiscal 2017.
- Protara Therapeutics, Inc. other nonoperating income (expense) for fiscal 2017 was $139.00K.
- Protara Therapeutics, Inc. other nonoperating income (expense) for fiscal 2016 was -$14.00K.
- Protara Therapeutics, Inc. other nonoperating income (expense) for fiscal 2015 was -$651.00K, a 112.84% decline from fiscal 2014.
| Period end | Other Nonoperating Income (Expense) 3 month | Other Nonoperating Income (Expense) 3 month as first filed | Other Nonoperating Income (Expense) 6 month | Other Nonoperating Income (Expense) 9 month | Other Nonoperating Income (Expense) 9 month as first filed | Other Nonoperating Income (Expense) 12 month |
|---|---|---|---|---|---|---|
| 2019-09-30 | $2.00K 10-Q · filed 2019-10-31 | $0.00 derived: sum of 2 quarters · filed 2019-10-31 | $1.00K 10-Q · filed 2019-10-31 | $2.00K derived: sum of 4 quarters · filed 2020-03-20 | ||
| 2019-06-30 | -$2.00K 10-Q · filed 2019-08-07 | -$1.00K 10-Q · filed 2019-08-07 | $0.00 derived: sum of 3 quarters · filed 2020-03-20 | -$1.00K derived: sum of 4 quarters · filed 2020-03-20 | ||
| 2019-03-31 | $1.00K 10-Q · filed 2019-05-08 | $2.00K derived: sum of 2 quarters · filed 2020-03-20 | $1.00K derived: sum of 3 quarters · filed 2020-03-20 | $16.00K derived: sum of 4 quarters · filed 2020-03-20 | ||
| 2018-12-31 | $1.00K derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-20 | $0.00 derived: sum of 2 quarters · filed 2020-03-20 | $15.00K derived: sum of 3 quarters · filed 2020-03-20 | $207.00K 10-K · filed 2020-03-20 | ||
| 2018-09-30 | -$1.00K 10-Q · filed 2019-10-31 | $14.00K derived: sum of 2 quarters · filed 2019-10-31 | $206.00K 10-Q · filed 2019-10-31 | $147.00K derived: sum of 4 quarters · filed 2019-10-31 | ||
| 2018-06-30 | $15.00K 10-Q · filed 2019-08-07 | $207.00K 10-Q · filed 2019-08-07 | $148.00K derived: sum of 3 quarters · filed 2019-08-07 | $64.00K derived: sum of 4 quarters · filed 2019-08-07 | ||
| 2018-03-31 | $192.00K 10-Q · filed 2019-05-08 | $133.00K derived: sum of 2 quarters · filed 2019-05-08 | $49.00K derived: sum of 3 quarters · filed 2019-05-08 | $381.00K derived: sum of 4 quarters · filed 2019-05-08 | ||
| 2017-12-31 | -$59.00K derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-13 | -$143.00K derived: sum of 2 quarters · filed 2019-03-13 | $189.00K derived: sum of 3 quarters · filed 2019-03-13 | $139.00K 10-K · filed 2019-03-13 | ||
| 2017-09-30 | -$84.00K 10-Q · filed 2018-11-07 | $248.00K derived: sum of 2 quarters · filed 2018-11-07 | $198.00K 10-Q · filed 2018-11-07 | $64.00K derived: sum of 4 quarters · filed 2019-03-13 | ||
| 2017-06-30 | $332.00K 10-Q · filed 2018-08-07 | $282.00K 10-Q · filed 2018-08-07 | $148.00K derived: sum of 3 quarters · filed 2019-03-13 | $161.00K derived: sum of 4 quarters · filed 2019-03-13 | ||
| 2017-03-31 | -$50.00K 10-Q · filed 2018-05-09 | -$184.00K derived: sum of 2 quarters · filed 2019-03-13 | -$171.00K derived: sum of 3 quarters · filed 2019-03-13 | -$275.00K derived: sum of 4 quarters · filed 2019-03-13 | ||
| 2016-12-31 | -$134.00K derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-13 | -$121.00K derived: sum of 2 quarters · filed 2019-03-13 | -$225.00K derived: sum of 3 quarters · filed 2019-03-13 | -$14.00K 10-K · filed 2019-03-13 | ||
| 2016-09-30 | $13.00K 10-Q · filed 2017-11-07 | -$91.00K derived: sum of 2 quarters · filed 2017-11-07 | $120.00K 10-Q · filed 2017-11-07 | -$68.00K derived: sum of 4 quarters · filed 2018-03-14 | ||
| 2016-06-30 | -$104.00K 10-Q · filed 2017-08-07 | $107.00K 10-Q · filed 2017-08-07 | -$81.00K derived: sum of 3 quarters · filed 2018-03-14 | -$416.00K derived: sum of 4 quarters · filed 2018-03-14 | ||
| 2016-03-31 | $211.00K 10-Q · filed 2017-05-10 | $23.00K derived: sum of 2 quarters · filed 2018-03-14 | -$312.00K derived: sum of 3 quarters · filed 2018-03-14 | -$440.00K derived: sum of 4 quarters · filed 2018-03-14 | ||
| 2015-12-31 | -$188.00K derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-14 | -$523.00K derived: sum of 2 quarters · filed 2018-03-14 | -$651.00K derived: sum of 3 quarters · filed 2018-03-14 | -$651.00K 10-K · filed 2018-03-14 | ||
| 2015-09-30 | -$335.00K 10-Q · filed 2016-11-07 | -$463.00K derived: sum of 2 quarters · filed 2016-11-07 | -$463.00K 10-Q · filed 2016-11-07 | |||
| 2015-06-30 | -$128.00K 10-Q · filed 2016-08-08 | -$128.00K 10-Q · filed 2016-08-08 | ||||
| 2014-12-31 | $10.49M derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-16 | $5.17M derived: sum of 2 quarters · filed 2017-03-16 | $5.14M derived: sum of 3 quarters · filed 2017-03-16 | $5.07M 10-K · filed 2017-03-16 | ||
| 2014-09-30 | -$5.33M 10-Q · filed 2015-11-12 | -$5.32M 10-Q · filed 2014-11-25 | -$5.35M derived: sum of 2 quarters · filed 2015-11-12 | -$5.42M 10-Q · filed 2015-11-12 | -$6.27M 10-Q · filed 2014-11-25 | -$5.18M derived: sum of 4 quarters · filed 2016-03-14 |
| 2014-06-30 | -$29.00K 10-Q · filed 2015-08-13 | -$99.00K 10-Q · filed 2015-08-13 | $149.00K derived: sum of 3 quarters · filed 2016-03-14 | -$40.00K derived: sum of 4 quarters · filed 2016-03-14 | ||
| 2014-03-31 | -$70.00K 10-Q · filed 2015-05-13 | $178.00K derived: sum of 2 quarters · filed 2016-03-14 | -$11.00K derived: sum of 3 quarters · filed 2016-03-14 | |||
| 2013-12-31 | $248.00K derived: 10-K 12 month − 10-Q 9 month · filed 2016-03-14 | $59.00K derived: sum of 2 quarters · filed 2016-03-14 | $67.00K 10-K · filed 2016-03-14 | |||
| 2013-09-30 | -$189.00K 10-Q · filed 2014-11-25 | -$181.00K 10-Q · filed 2014-11-25 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Compass Therapeutics, Inc. (CMPX) | United States | $0.204B | -5.35 |
| Alpha Cognition Inc. (ACOG) | $0.185B | -6.77 | |
| Alector, Inc. (ALEC) | United States | $0.213B | -1.90 |
| Coherus Oncology, Inc. (CHRS) | United States | $0.182B | -1.63 |
| ANAVEX LIFE SCIENCES CORP. (AVXL) | United States | $0.218B | -18.37 |
| Protalix BioTherapeutics, Inc. (PLX) | $0.221B | 9.87 | |
| PRECISION BIOSCIENCES INC (DTIL) | United States | $0.175B | -3.95 |
| Voyager Therapeutics, Inc. (VYGR) | United States | $0.173B | -1.99 |
| Acumen Pharmaceuticals, Inc. (ABOS) | United States | $0.162B | -1.83 |
| Outlook Therapeutics, Inc. (OTLK) | United States | $0.162B | -4.90 |